Targeting the Kaposi's sarcoma-associated herpesvirus genome with the CRISPR-Cas9 platform in latently infected cells.

Targeting of orf73 resulted in a moderate, but highly significant, decrease of GFP expression that was evident only in cells grown in the absence of hygromycin selection (Fig. 1 ).

also in 132,142 other papers